{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:16Z","timestamp":1791920896909,"version":"4.3.4"},"publisher-location":"Cham","reference-count":118,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030035013","type":"print"},{"value":"9783030035020","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-03502-0_1","type":"book-chapter","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T14:50:23Z","timestamp":1544107823000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["AIDS-Associated Malignancies"],"prefix":"10.1007","author":[{"given":"Ramya","family":"Vangipuram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199505043321801","volume":"332","author":"PS Moore","year":"1995","unstructured":"Moore PS, Chang Y (1995) Detection of herpesvirus-like DNA sequences in Kaposi\u2019s sarcoma in patients with and without HIV infection. N Engl J Med 332:1181\u20131185","journal-title":"N Engl J Med"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186\u20131191","journal-title":"N Engl J Med"},{"key":"1_CR3","doi-asserted-by":"crossref","unstructured":"Soulier J, Grollet L, Oksenhendler E et al (1995) Kaposi\u2019s sarcoma-associated herpesvirus-likeDNAsequences in multicentric Castleman\u2019s disease. Blood 86:1276\u201380","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0025-6196(11)62256-8","volume":"77","author":"Z Grossman","year":"2002","unstructured":"Grossman Z, Isovich J, Schwartz F et al (2002) Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc 77:905\u2013909","journal-title":"Mayo Clin Proc"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bjc.6690782","volume":"81","author":"D Alblashi","year":"1999","unstructured":"Alblashi D, Chatlynne L, Cooper H et al (1999) Seroprevalence of human herpesvirus-8 (HHV-8) in countries of southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 81:893\u2013897","journal-title":"Br J Cancer"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","volume":"338","author":"N Martin","year":"1998","unstructured":"Martin N, Ganem D, Osmond D, Page-Shager D et al (1998) Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338:948\u2013954","journal-title":"N Engl J Med"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/314926","volume":"180","author":"N Smith","year":"1999","unstructured":"Smith N, Sabin C, Gopal R et al (1999) Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 180:600\u2013606","journal-title":"J Infect Dis"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ijc.22281","volume":"120","author":"E Martro","year":"2007","unstructured":"Martro E, Esteve A, Schulz T et al (2007) Risk factors for human herpesvirus 8 infection and AIDS-associated Kaposi\u2019s sarcoma among men who have sex with men in a European multicentre study. Int J Cancer 120:1129\u20131135","journal-title":"Int J Cancer"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/509621","volume":"195","author":"C Casper","year":"2007","unstructured":"Casper C, Krantz E, Selke S et al (2007) Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J Infect Dis 195:30\u201336","journal-title":"J Infect Dis"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/oxfordjournals.aje.a010196","volume":"151","author":"J Martin","year":"2000","unstructured":"Martin J, Osmond D (2000) Invited commentary: determining specific sexual practices associated with human herpesvirus 8 transmission. Am J Epidemiol 151:225\u2013229","journal-title":"Am J Epidemiol"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/598978","volume":"48","author":"T Campbell","year":"2009","unstructured":"Campbell T, Borok M, Ndemara B et al (2009) Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe. Clin Infect Dis 48:1601\u20131608","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jdcr.2017.04.012","volume":"3","author":"T Hinojosa","year":"2017","unstructured":"Hinojosa T, Lewis DJ, Liu M, Garza G, Vangipuram R, Ramos E, Salas-Alanis JC, Nawas ZY, Tyring SK (2017) Nonepidemic Kaposi sarcoma: a recently proposed category. JAAD Case Rep 3(5):441\u2013443","journal-title":"JAAD Case Rep"},{"issue":"8","key":"1_CR13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.1969.03150210077009","volume":"207","author":"John H. Siegel","year":"1969","unstructured":"Siegel JH, Janis R, Alper JC et al (1969) Disseminaed visceral Kaposi\u2019s sarcoma. Apperance after human renal homograft operation. JAMA 207(8):1493\u20131496","journal-title":"JAMA"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","volume":"99","author":"RJ Biggar","year":"2007","unstructured":"Biggar RJ, Chatruvedi AK, Goederr JJ, Engels EA (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962\u2013972","journal-title":"J Natl Cancer Inst"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/507648","volume":"194","author":"A Guihot","year":"2006","unstructured":"Guihot A, Dupin N, Marcelin AG et al (2006) Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 194:1078\u20131088","journal-title":"J Infect Dis"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","volume":"20","author":"MJ Silverberg","year":"2011","unstructured":"Silverberg MJ, Chao C, Leyden WA et al (2011) HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 20:2551\u20132559","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","volume":"32","author":"SM Mbulaiteye","year":"2003","unstructured":"Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA (2003) Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32:527\u2013533","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"1_CR18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","volume":"20","author":"Eric A Engels","year":"2006","unstructured":"Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980\u20132002. AIDS 20:1645\u20131654","journal-title":"AIDS"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","volume":"117","author":"EP Simard","year":"2011","unstructured":"Simard EP, Pfeiffer RM, Engels EA (2011) Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 117:1089\u20131096","journal-title":"Cancer"},{"issue":"5","key":"1_CR20","first-page":"236","volume":"14","author":"BJ Dezube","year":"2004","unstructured":"Dezube BJ, Pantanowitz L, Aboulafia DM (2004) Management of AIDS-related Kaposi sarcoma advences in target discover and treatment. AIDS Read 14(5):236\u2013351","journal-title":"AIDS Read"},{"issue":"6","key":"1_CR21","first-page":"715","volume":"86","author":"JB Danzig","year":"1991","unstructured":"Danzig JB, Brandt LJ, Reinus JF, Klein RS (1991) Gastrointestinal malignancy in patients with AIDS. Am J Gastrotenterol 86(6):715\u2013718","journal-title":"Am J Gastrotenterol"},{"issue":"2","key":"1_CR22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0036-1578803","volume":"37","author":"K Sigel","year":"2016","unstructured":"Sigel K, Pitts R, Crothers K (2016) Lung Malignancies in HIV Infection. Semin Respir Crit Care Med 37(2):267\u2013276","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"1_CR23","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","volume":"15","author":"S E Krown","year":"1997","unstructured":"Krown SE, Testa MA, Huang J (1997) AIDS-related Kaposi\u05f3s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS clinical trials group oncology committee. J Clin Oncol 15:3085\u20133092","journal-title":"Journal of Clinical Oncology"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2003.10.162","volume":"21","author":"G Nasti","year":"2003","unstructured":"Nasti G, Talamini R, Antinori A et al (2003) AIDS-related Kaposi\u2019s Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS clinical trial group staging system in the Haart Era\u2014the Italian cooperative group on AIDS and tumors and the Italian Cohort of Patients Naive from Antiretrovirals. J Clin Oncol 21:2876\u20132882","journal-title":"J Clin Oncol"},{"key":"1_CR25","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","volume":"92","author":"International Collaboration on HIV and Cancer","year":"2000","unstructured":"International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823\u20131830","journal-title":"J Natl Cancer Inst"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","volume":"13","author":"M Bower","year":"1999","unstructured":"Bower M, Fox P, Fife J et al (1999) Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi\u2019s sarcoma. AIDS 13:2105\u20132111","journal-title":"AIDS"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","volume":"22","author":"SE Krown","year":"2004","unstructured":"Krown SE (2004) Highly active antiretroviral therapy in AIDS-associated Kaposi\u2019s sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi\u2019s sarcoma. J Clin Oncol 22:399\u2013402","journal-title":"J Clin Oncol"},{"issue":"13","key":"1_CR28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","volume":"23","author":"Mark Bower","year":"2009","unstructured":"Bower M, Weir J, Francis N et al (2009) The effect of HAART in 254 consecutive patients with AIDS-related Kaposi\u2019s sarcoma. AIDS 23:1701\u20131706","journal-title":"AIDS"},{"issue":"9","key":"1_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(03)01192-6","volume":"4","author":"C Sgadari","year":"2003","unstructured":"Sgadari C, Monini P, Brillari F, Ensoli B (2003) Use of HIV protease inhibitors to block Kaposi\u2019s sarcoma and tumour growth. Lancet Oncol 4(9):537\u2013547","journal-title":"Lancet Oncol"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.bjc.6603056","volume":"94","author":"V Martinez","year":"2006","unstructured":"Martinez V, Caumes E, Gabotti L et al (2006) Remission from Kaposi\u2019s sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. Br J Cancer 94:1000\u20131006","journal-title":"Br J Cancer"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2000.18.7.1550","volume":"18","author":"G Nasti","year":"2000","unstructured":"Nasti G, Errante D, Talamini R et al (2000) Vinorelbine is an effective and safe drug for AIDS-related Kaposi\u2019s sarcoma: results of a phase II study. J Clin Oncol 18:1550\u20131557","journal-title":"J Clin Oncol"},{"issue":"8966","key":"1_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(95)92654-2","volume":"346","author":"MW Saville","year":"1995","unstructured":"Saville MW, Lietzau J, Pluda JM, Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S et al (1995) Treatment of HIV-associated Kaposi\u2019s sarcoma with paclitaxel. Lancet 346(8966):26\u201328","journal-title":"Lancet"},{"issue":"13","key":"1_CR33","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","volume":"18","author":"Richard F. Little","year":"2000","unstructured":"Little RF, Wyvill KM, Pluda JM et al (2000) Activity of thalidomide in AIDS-related Kaposi\u2019s sarcoma. J Clin Oncol 18:2593\u20132602","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"1_CR34","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","volume":"24","author":"Bruce J. Dezube","year":"2006","unstructured":"Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM (2006) Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u05f3s sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 24:1389\u20131394","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"1_CR35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822\u2013830","journal-title":"Cancer"},{"issue":"6","key":"1_CR36","first-page":"636","volume":"20","author":"BA Peterson","year":"1993","unstructured":"Peterson BA, Frizzera G (1993) Multicentric Castelman\u2019s disease. Semin Oncol 20(6):636\u2013647","journal-title":"Semin Oncol"},{"issue":"1","key":"1_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/83.1.27","volume":"83","author":"NA Lachant","year":"1985","unstructured":"Lachant NA, Sun NC, Leong LA et al (1985) Multicentric angiofollicular lymph node hyperplasia (Casttleman\u2019s disease) followed by Kaposi\u2019s sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 83(1):27\u201333","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"1_CR38","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","volume":"99","author":"E Oksenhendler","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier E et al (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99(7):2331\u20132336","journal-title":"Blood"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","volume":"20","author":"T Powles","year":"2009","unstructured":"Powles T, Stebbing J, Bazeos A et al (2009) The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman\u2019s disease. Ann Oncol 20:775\u2013779","journal-title":"Ann Oncol"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","volume":"10","author":"E Oksenhendler","year":"1996","unstructured":"Oksenhendler E, Duarte M, Soulier J et al (1996) Multicentric Castleman\u2019s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 10:61\u201367","journal-title":"AIDS"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069","volume":"96","author":"E Oksenhendler","year":"2000","unstructured":"Oksenhendler E, Carcelain G, Aoki Y et al (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96:2069\u20132073","journal-title":"Blood"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","volume":"122","author":"MN Polizzotto","year":"2013","unstructured":"Polizzotto MN, Uldrick TS, Wang V et al (2013) Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood 122:4189\u20134198","journal-title":"Blood"},{"issue":"2","key":"1_CR43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.seminoncol.2014.12.027","volume":"42","author":"Manisha Bhutani","year":"2015","unstructured":"Bhutani M, Polizzotto MN, Uldrick TS, Yarchoan R (2015) Kaposi Sarcoma\u2013associated Herpesvirus-associated Malignancies: epidemiology, pathogenesis, and advances in treatment. Semin Oncol 42(2):223\u2013246","journal-title":"Seminars in Oncology"},{"key":"1_CR44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2012.00073","volume":"3","author":"MN Polizzotto","year":"2012","unstructured":"Polizzotto MN, Uldrick TS, Hu D, Yarchoan R (2012) Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome. Front Microbiol 3:73","journal-title":"Front Microbiol"},{"issue":"22","key":"1_CR45","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","volume":"25","author":"L Gerard","year":"2007","unstructured":"Gerard L, Berezne A, Galicier L et al (2007) Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman\u2019s disease: ANRS 117 CastlemaB Trial. J Clin Oncol 25(22):3350\u20133356","journal-title":"J Clin Oncol"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/QAI.0b013e3182a8338f","volume":"65","author":"M Bower","year":"2014","unstructured":"Bower M, Pria AD, Coyle M et al (2014) Diagnostic criteria schemes for multicentric Castleman disease in 75 cases. J Acquir Immune Defic Syndr 65:e80\u2013e82","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1_CR47","first-page":"25","volume":"10","author":"EE Mylona","year":"2008","unstructured":"Mylona EE, Baranoutis IG, Lekakis LJ et al (2008) Castleman\u2019s disease in HIV infection: a systematic review of the literature. AIDS Rev 10:25\u201335","journal-title":"AIDS Rev"},{"key":"1_CR48","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1200\/JCO.2010.34.1909","volume":"29","author":"M Bower","year":"2011","unstructured":"Bower M, Newsom-Davis T, Naresh K et al (2011) Clinical features and outcome in HIV-associated multicentric Castleman\u2019s disease. J Clin Oncol 29:2481\u20132486","journal-title":"J Clin Oncol"},{"key":"1_CR49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.2005.00570.x","volume":"76","author":"M Ide","year":"2006","unstructured":"Ide M, Kawahi Y, Izumi Y et al (2006) Long-term remission in HIV-negative patients with multicentric Castleman\u2019s disease using rituximab. Eur J Haematol 76:119\u2013123","journal-title":"Eur J Haematol"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6890-8-7","volume":"8","author":"L Pantanowitz","year":"2008","unstructured":"Pantanowitz L, Fruh K, Marconi S et al (2008) Pathology of rituximab-induced Kaposi sarcoma flare. BMC Clin Pathol 8:7","journal-title":"BMC Clin Pathol"},{"key":"1_CR51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","volume":"15","author":"F Rhee Van","year":"2014","unstructured":"Van Rhee F, Wong RS, Munshi N et al (2014) Siltuximab for multicentric Castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol 15:966\u2013974","journal-title":"Lancet Oncol"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3960\/jslrt.53.69","volume":"53","author":"H Kawabata","year":"2013","unstructured":"Kawabata H, Kadowaki N, Nishikori M et al (2013) Clinical features and treatment of multicentric castleman\u2019s disease: a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop 53:69\u201377","journal-title":"J Clin Exp Hematop"},{"key":"1_CR53","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1158\/1078-0432.CCR-12-3349","volume":"19","author":"R Kurzrock","year":"2013","unstructured":"Kurzrock R, Voorhees PM, Casper C et al (2013) A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-hodgkin lymphoma, multiple myeloma, or castleman disease. Clin Cancer Res 19:3659\u20133670","journal-title":"Clin Cancer Res"},{"key":"1_CR54","doi-asserted-by":"crossref","unstructured":"Knowles DM, Inghirami G, Ubriaco A et al (1989) Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood (73)3:792\u2013799","DOI":"10.1182\/blood.V73.3.792.792"},{"key":"1_CR55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","volume":"88","author":"RG Nador","year":"1996","unstructured":"Nador RG, Cesarman E, Chadburn A et al (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u05f3s sarcoma-associated herpes virus. Blood 88:645\u2013656","journal-title":"Blood"},{"key":"1_CR56","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","volume":"23","author":"E Boulanger","year":"2005","unstructured":"Boulanger E, Gerard L, Gabarre J et al (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23:4372\u20134380","journal-title":"J Clin Oncol"},{"key":"1_CR57","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","volume":"28","author":"A Chadburn","year":"2004","unstructured":"Chadburn A, Hyjek E, Mathew E et al (2004) KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28:1401\u20131416","journal-title":"Am J Surg Pathol"},{"key":"1_CR58","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS et al (1995) Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186\u20131191","journal-title":"N Engl J Med"},{"issue":"4","key":"1_CR59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MCP.0000000000000384","volume":"23","author":"N Arora","year":"2017","unstructured":"Arora N, Gupta A, Sadeghi N (2017) Primary effusion lymphoma: current concepts and management. Curr Opin Pulm Med 23(4):365\u2013370","journal-title":"Curr Opin Pulm Med"},{"key":"1_CR60","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/leu.2009.117","volume":"23","author":"P Gasperini","year":"2009","unstructured":"Gasperini P, Tosato G (2009) Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Leukemia 23:1867\u20131874","journal-title":"Leukemia"},{"key":"1_CR61","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2013-01-481713","volume":"122","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Ashlock BM, Natkunam Y et al (2013) CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma. Blood 122:1233\u20131242","journal-title":"Blood"},{"key":"1_CR62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG (2016) Epstein-Barr virus: more than 50\u00a0years old and still providing surprises. Nat Rev Cancer 16:789\u2013802","journal-title":"Nat Rev Cancer"},{"key":"1_CR63","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jcp.56.3.188","volume":"56","author":"C Bellan","year":"2003","unstructured":"Bellan C, Lazzi S, DeFalco G et al (2003) Burkitt\u2019s lymphoma: new insights into molecular pathogenesis. J Clin Pathol 56:188\u2013193","journal-title":"J Clin Pathol"},{"issue":"9","key":"1_CR64","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/v4091687","volume":"4","author":"D Ramalingam","year":"2012","unstructured":"Ramalingam D, Kieffer-Kwon P, Ziegelbauer JM (2012) Emerging themes from EBV and KSHV microRNA targets. Viruses 4(9):1687\u20131710","journal-title":"Viruses"},{"issue":"6","key":"1_CR65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.semcancer.2009.10.001","volume":"19","author":"N Nagy","year":"2009","unstructured":"Nagy N, Klein G, Klein E (2009) To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes. Semin Cancer Biol 19(6):407\u2013410","journal-title":"Semin Cancer Biol"},{"key":"1_CR66","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831\u2013840","journal-title":"Cell"},{"key":"1_CR67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-8588(03)00050-9","volume":"17","author":"D Knowles","year":"2003","unstructured":"Knowles D (2003) Etiology and pathogenesis of AIDS-related non-Hodgkin\u2019s lymphoma. Hematol Oncol Clin N Am 17:785\u2013820","journal-title":"Hematol Oncol Clin N Am"},{"key":"1_CR68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","volume":"32","author":"SM Mbulaiteye","year":"2003","unstructured":"Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA (2003) Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32:527\u2013533","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"1_CR69","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0889-8588(05)70393-2","volume":"10","author":"Kenneth L. McClain","year":"1996","unstructured":"McClain KL, Joshi VV, Murphy SB (1996) Cancers in children with HIV infection. Hematol Oncol Clin North Am 10:1189\u20131201","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"1_CR70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","volume":"319","author":"B Ledergerber","year":"1999","unstructured":"Ledergerber B, Telenti A, Egger M (1999) Risk of HIV related Kaposi\u2019s sarcoma and Non-Hodgkin\u2019s lymphoma with potent antiretroviral therapy: prospective cohort study. Br Med J 319:23\u201324","journal-title":"Br Med J"},{"key":"1_CR71","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1200\/JCO.2004.11.097","volume":"22","author":"J Stebbing","year":"2004","unstructured":"Stebbing J, Gazzard B, Mandalia S et al (2004) Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin\u2019s lymphoma. J Clin Oncol 22:2177\u20132183","journal-title":"J Clin Oncol"},{"issue":"8","key":"1_CR72","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","volume":"98","author":"C. Besson","year":"2001","unstructured":"Besson C, Goubar A, Gabarre J et al (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339\u20132344 [PubMed]","journal-title":"Blood"},{"key":"1_CR73","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","volume":"20","author":"EA Engels","year":"2006","unstructured":"Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980\u20132002. AIDS 20:1645\u20131654","journal-title":"AIDS"},{"key":"1_CR74","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","volume":"117","author":"EP Simard","year":"2011","unstructured":"Simard EP, Pfeiffer RM, Engels EA (2011) Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 117:1089\u20131096","journal-title":"Cancer"},{"issue":"8","key":"1_CR75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/656416","volume":"51","author":"Edgar\u00a0P. Simard","year":"2010","unstructured":"Simard EP, Engels EA (2010) Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis 51(8):957\u2013962","journal-title":"Clinical Infectious Diseases"},{"key":"1_CR76","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","volume":"60","author":"KL Grogg","year":"2007","unstructured":"Grogg KL, Miller RF, Dogan A (2007) HIV infection and lymphoma. J Clin Pathol 60:1365\u20131372","journal-title":"J Clin Pathol"},{"key":"1_CR77","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-010-0252-3","volume":"101","author":"S Bayraktar","year":"2011","unstructured":"Bayraktar S, Bayraktar UD, Ramos JC et al (2011) Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors. J Neuro-Oncol 101:257\u2013265","journal-title":"J Neuro-Oncol"},{"key":"1_CR78","first-page":"199","volume":"9","author":"LZ Raez","year":"1998","unstructured":"Raez LZ, Patel P, Feun L et al (1998) Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Crit Rev Oncog 9:199\u2013208","journal-title":"Crit Rev Oncog"},{"issue":"7","key":"1_CR79","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","volume":"16","author":"K Hoang-Xuan","year":"2015","unstructured":"Hoang-Xuan K, Bessell E, Bromberg J (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 16(7):e322\u2013e332. https:\/\/doi.org\/10.1016\/S1470-2045(15)00076-5","journal-title":"Lancet Oncol"},{"key":"1_CR80","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","volume":"116","author":"M Guech-Ongey","year":"2010","unstructured":"Guech-Ongey M, Simard EP, Anderson WF et al (2010) AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology? Blood 116:5600\u20135604","journal-title":"Blood"},{"key":"1_CR81","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","volume":"16","author":"F Davi","year":"1998","unstructured":"Davi F, Delecluse HJ, Guiet P et al (1998) Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin\u2019s lymphomas. J Clin Oncol 16:3788\u20133795","journal-title":"J Clin Oncol"},{"key":"1_CR82","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3109\/10428194.2013.878933","volume":"55","author":"B Xicoy","year":"2014","unstructured":"Xicoy B, Ribera JM, M\u00fcller M et al (2014) Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma\/leukemia: parallel study of 81 patients. Leuk Lymphoma 55:2341\u20132348","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"1_CR83","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","volume":"23","author":"ST Lim","year":"2005","unstructured":"Lim ST, Karim R, Nathwani BN (2005) AIDS-related Burkitt\u2019s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430\u20134438 Epub 2005 May 9","journal-title":"J Clin Oncol"},{"issue":"1","key":"1_CR84","doi-asserted-by":"publisher","first-page":"e2014064","DOI":"10.4084\/MJHID.2014.064","volume":"6","author":"M Bibas","year":"2014","unstructured":"Bibas M, Castillo JJ (2014) Current knowledge on HIV-associated Plasmablastic Lymphoma. Mediterr J Hematol Infect Dis 6(1):e2014064. https:\/\/doi.org\/10.4084\/MJHID.2014.064","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"1_CR85","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","volume":"89","author":"HJ Delecluse","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413\u20131420","journal-title":"Blood"},{"key":"1_CR86","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","volume":"15","author":"J Teruya-Feldstein","year":"2004","unstructured":"Teruya-Feldstein J, Chiao E, Filippa DA et al (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15:1673\u20131679","journal-title":"Ann Oncol"},{"key":"1_CR87","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","volume":"118","author":"JJ Castillo","year":"2012","unstructured":"Castillo JJ, Furman M, Beltr\u00e1n BE et al (2012) Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer 118:5270\u20135277","journal-title":"Cancer"},{"key":"1_CR88","first-page":"1377","volume":"16","author":"MR Pinzone","year":"2012","unstructured":"Pinzone MR, Fiorica F, Di Rosa M et al (2012) Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci 16:1377\u20131388","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1_CR89","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1182\/blood-2010-08-301531","volume":"117","author":"J Bohlius","year":"2011","unstructured":"Bohlius J, Schmidlin K, Bou\u00e9 F et al (2011) HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes. Blood 117:6100\u20136108","journal-title":"Blood"},{"key":"1_CR90","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/1097-0142(19900515)65:10<2248::AID-CNCR2820651015>3.0.CO;2-W","volume":"65","author":"M Serrano","year":"1990","unstructured":"Serrano M, Bellas C, Campo E et al (1990) Hodgkin\u2019s disease in patients with antibodies to human immunodeficiency virus: a study of 22 patients. Cancer 65:2248\u20132254","journal-title":"Cancer"},{"issue":"13","key":"1_CR91","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"Frank J. Palella","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 338:853\u2013860","journal-title":"New England Journal of Medicine"},{"key":"1_CR92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3324\/haematol.10479","volume":"92","author":"B Xicoy","year":"2007","unstructured":"Xicoy B, Ribera JM, Miralles P et al (2007) Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin\u2019s lymphoma. Haematologica 92:191\u2013198","journal-title":"Haematologica"},{"issue":"suppl 8","key":"1_CR93","doi-asserted-by":"crossref","first-page":"S849","DOI":"10.1093\/cid\/civ813","volume":"61","author":"IU Park","year":"2015","unstructured":"Park IU, Introcaso C, Dunne EF (2015) Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 61(suppl 8):S849\u2013S855","journal-title":"Clin Infect Dis"},{"issue":"9581","key":"1_CR94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581):59\u201367","journal-title":"Lancet"},{"key":"1_CR95","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-0-387-46816-7_7","volume":"133","author":"JE Cameron","year":"2007","unstructured":"Cameron JE, Hagensee ME (2007) Human papillomavirus infection and disease in the HIV+ individual. Cancer Treat Res 133:185\u2013213","journal-title":"Cancer Treat Res"},{"key":"1_CR96","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1128\/JVI.00093-14","volume":"88","author":"Y Ma","year":"2014","unstructured":"Ma Y, Madupu R, Karaoz U et al (2014) Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets. J Virol 88:4786\u20134797","journal-title":"J Virol"},{"key":"1_CR97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"1_CR98","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"D. Maxwell Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chapter 2: the burden of HPV-related cancers. Vaccine 24(Suppl. 3):11\u201325","journal-title":"Vaccine"},{"issue":"12","key":"1_CR99","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/infdis\/jis627","volume":"206","author":"S. Hariri","year":"2012","unstructured":"Hariri S, Unger ER, Powell SE et al (2012) Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis 206(12):1878\u20131886 [PubMed]","journal-title":"Journal of Infectious Diseases"},{"key":"1_CR100","doi-asserted-by":"crossref","unstructured":"Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA (2015) Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst 107(4)","DOI":"10.1093\/jnci\/dju503"},{"issue":"8","key":"1_CR101","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","volume":"283","author":"TV Ellerbrock","year":"2000","unstructured":"Ellerbrock TV, Chiasson MA, Bush TJ et al (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283(8):1031\u20131037","journal-title":"JAMA"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550\u2013560. https:\/\/doi.org\/10.1038\/nrc2886","journal-title":"Nat Rev Cancer"},{"key":"1_CR103","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1200\/JCO.2012.44.5486","volume":"30","author":"C Piketty","year":"2012","unstructured":"Piketty C, Selinger-Leneman H, Bouvier AM (2012) Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 30:4360\u20134366","journal-title":"J Clin Oncol"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","volume":"92","author":"M Frisch","year":"2000","unstructured":"Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500\u20131510. https:\/\/doi.org\/10.1093\/jnci\/92.18.1500","journal-title":"J Natl Cancer Inst"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcv.2004.10.020","volume":"32","author":"Charles J.N. Lacey","year":"2005","unstructured":"Lacey CJ (2005) Therapy for genital human papillomavirus-related disease. J Clin Virol 32(Suppl. S1):82\u201390. https:\/\/doi.org\/10.1016\/j.jcv.2004.10.020","journal-title":"Journal of Clinical Virology"},{"issue":"1","key":"1_CR106","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/coh.0b013e328319bcbe","volume":"4","author":"Isabelle Heard","year":"2009","unstructured":"Heard I (2009) Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS 4:63\u201373. https:\/\/doi.org\/10.1097\/coh.0b013e328319bcbe [PubMed] [Cross Ref]","journal-title":"Current Opinion in HIV and AIDS"},{"key":"1_CR107","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1086\/652408","volume":"201","author":"JS Smith","year":"2010","unstructured":"Smith JS, Moses S, Hudgens M, Parker CB, Agot K, Maclean I et al (2010) Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 201:1677\u20131685","journal-title":"J Infect Dis"},{"key":"1_CR108","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/QAD.0b013e32832b4449","volume":"23","author":"PV Chin-Hong","year":"2009","unstructured":"Chin-Hong PV, Husnik M, Cranston RD et al (2009) Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 23:1135\u20131142","journal-title":"AIDS"},{"key":"1_CR109","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","volume":"101","author":"AK Chaturvedi","year":"2009","unstructured":"Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA (2009) Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 101:1120\u20131130","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1_CR110","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/jcm4020260","volume":"4","author":"NM Reusser","year":"2015","unstructured":"Reusser NM, Downing C, Guidry J, Tyring SK (2015) HPV carcinomas in immunocompromised patients. J Clin Med 4(2):260\u2013281. https:\/\/doi.org\/10.3390\/jcm4020260","journal-title":"J Clin Med"},{"key":"1_CR111","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12029-013-9543-1","volume":"44","author":"JE Meyer","year":"2013","unstructured":"Meyer JE, Panico VJA, Marconato HMF et al (2013) HIV positivity but not HPV\/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer 44:450\u2013455","journal-title":"J Gastrointest Cancer"},{"issue":"8","key":"1_CR112","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v21.i8.2294","volume":"21","author":"M Ghosn","year":"2015","unstructured":"Ghosn M, Kourie HR, Abdayem P, Antoun J, Nasr D (2015) Anal cancer treatment: current status and future perspectives. World J Gastroenterol 21(8):2294\u20132302","journal-title":"World J Gastroenterol"},{"key":"1_CR113","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1479-5876-7-108","volume":"7","author":"SH Burg van der","year":"2009","unstructured":"van der Burg SH, Palefsky JM (2009) Human immunodeficiency virus and human papilloma virus\u2014why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med 7:108","journal-title":"J Transl Med"},{"key":"1_CR114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/apc.1998.12.251","volume":"12","author":"PD Abercrombie","year":"1998","unstructured":"Abercrombie PD, Korn AP (1998) Vulvar intraepithelial neoplasia in women with HIV. AIDS Patient Care STDS 12:251\u2013254","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"1_CR115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.AOG.0000210237.80211.ff","volume":"107","author":"Denise J. Jamieson","year":"2006","unstructured":"Jamieson DJ, Paramsothy P, Cu-Uvin S et al (2006) HIV epidemiology research study group. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 107:1023\u20131028","journal-title":"Obstetrics & Gynecology"},{"issue":"8","key":"1_CR116","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000226963.10342.f4","volume":"20","author":"Guillem Sirera","year":"2006","unstructured":"Sirera G, Videla S, Pinol M et al (2006) High prevalence of human papillomavirus infection in the anus, penis and mouth in HIVpositive men. AIDS 20:1201\u20131204","journal-title":"AIDS"},{"key":"1_CR117","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/1055-9965.EPI-11-0734","volume":"21","author":"DC Beachler","year":"2012","unstructured":"Beachler DC, Weber KM, Margolick JB et al (2012) Risk factors for oral HPV infection among a high prevalence population of HIV positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 21:122\u2013133","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1_CR118","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2004.10.020","volume":"32","author":"Charles J.N. Lacey","year":"2005","unstructured":"Lacey CJ (2005) Therapy for genital human papillomavirus-related disease. J Clin Virol 32(Suppl. S1):82\u201390","journal-title":"Journal of Clinical Virology"}],"container-title":["Cancer Treatment and Research","HIV\/AIDS-Associated Viral Oncogenesis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-03502-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:42:13Z","timestamp":1573062133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-03502-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"ISBN":["9783030035013","9783030035020"],"references-count":118,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-03502-0_1","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]}}}